| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698502 | Clinical Oncology | 2016 | 12 Pages |
Abstract
There is moderate quality evidence that conventionally fractionated CCRT improves survival outcomes compared with AFRT alone in the definitive radiotherapeutic management of locoregionally advanced HNSCC. No form of acceleration can potentially compensate fully for the lack of concurrent chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T. Gupta, S. Kannan, S. Ghosh-Laskar, J.P. Agarwal,